天目药业: 杭州天目山药业股份有限公司2025年第三次临时股东大会会议资料

Core Points - The company is holding its third extraordinary general meeting of shareholders in 2025 on September 12, 2025, to discuss key governance changes [1][2] - The main proposals include the cancellation of the supervisory board, amendments to the articles of association, and the establishment of new governance systems [3][4][6] Proposal Summaries Proposal 1: Cancellation of the Supervisory Board and Amendment of Articles of Association - The company proposes to cancel the supervisory board, transferring its powers to the audit committee of the board of directors, and amend the articles of association accordingly [4][5] - Changes will include replacing terms related to the supervisory board with references to the audit committee to ensure compliance with the revised Company Law [4] Proposal 2: Cancellation of the Supervisory Board and Abolition of Supervisory Meeting Rules - The company aims to abolish the supervisory meeting rules in conjunction with the cancellation of the supervisory board, with the audit committee assuming the relevant responsibilities [5] Proposal 3: Revision and Establishment of Company Governance Systems - The company plans to revise and establish certain governance systems to enhance operational standards and governance levels, in line with the latest legal and regulatory requirements [6]